Pustular psoriasis (excluding A localized)

Clinical trials for Pustular psoriasis (excluding A localized) explained in plain language.

Never miss a new study

Get alerted when new Pustular psoriasis (excluding A localized) trials appear

Sign up with your email to follow new studies for Pustular psoriasis (excluding A localized), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Higher dose offers new hope for psoriasis patients who stopped responding to standard therapy

Disease control Completed

This study tested a higher dose (10 mg/kg every 8 weeks) of the drug TA-650 in 51 adults with psoriasis who had initially improved on the standard dose of Remicade but later lost that benefit. The goal was to see if the increased dose could again reduce skin symptoms. Participant…

Matched conditions: PUSTULAR PSORIASIS (EXCLUDING A LOCALIZED)

Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

Pustular psoriasis (excluding A localized)

Get alerted when new Pustular psoriasis (excluding A localized) trials appear

Higher dose offers new hope for psoriasis patients who stopped responding to standard therapy